SUTRO BIOPHARMA INC — Form D/A
SUTRO BIOPHARMA INC of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2018-08-08. The offering totals $85.4M, of which $85.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-08-08
- Form: D/A
- Accession: 0001382101-18-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $85.4M
- Amount sold: $85.4M
- Remaining: $2
- Investors: 15
- Date of first sale: 2018-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-314024
Issuer
- Name: SUTRO BIOPHARMA INC
- CIK: 0001382101
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 310 UTAH AVE., SUITE 150, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-392-8412
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Michael Bryan Dybbs | Director | South San Francisco, CA |
| John G Freund | Director | Watertown, MA |
| Daniel J Janney | Director | South San Francisco, CA |
| Virgil Bryan Lawlis | Director | South San Francisco, CA |
| Joseph Bryan Lobacki | Director | South San Francisco, CA |
| William J Newell | Director | South San Francisco, CA |
| Daniel Bryan Petree | Director | South San Francisco, CA |
| Michael Bryan Ross | Director | South San Francisco, CA |
| Armen Bryan Shanafelt | Director | South San Francisco, CA |
| William J Newell | Executive Officer | South San Francisco, CA |
| Michael G Ross | Director | South San Francisco, CA |
| Bryan G Lawlis | Director | South San Francisco, CA |
| Armen G Shanafelt | Director | South San Francisco, CA |
| Joseph G Lobacki | Director | South San Francisco, CA |
Other filings by this issuer (1)
More